Clinical and molecular description of two cases of neonatal diabetes secondary to mutations in PDX1
Pancreatic dysgenesis (PD) is a rare congenital disease, with less than 100 cases reported in the literature. In most cases, patients are asymptomatic and the diagnosis is made incidentally. In this report, we present the case of two brothers with a history of intrauterine growth retardation, low bi...
Main Authors: | Nicolas Forero-Castro, Luis Carlos Ramirez, Juan Carlos Celis, Fernando Arturo Silva Henao, Fernando Leal Valencia |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2023-07-01
|
Series: | Endocrinology, Diabetes & Metabolism Case Reports |
Online Access: | https://edm.bioscientifica.com/view/journals/edm/2023/3/EDM22-0383.xml |
Similar Items
-
PDX-1: A Promising Therapeutic Target to Reverse Diabetes
by: Yanjiao Zhang, et al.
Published: (2022-11-01) -
Epigenetic Regulation of PDX-1 in Type 2 Diabetes Mellitus
by: Liu J, et al.
Published: (2021-02-01) -
Solution Structures and Dynamic Assembly of the 24-Meric Plasmodial Pdx1–Pdx2 Complex
by: Najeeb Ullah, et al.
Published: (2020-08-01) -
Molecular activated recombination in divertor simulation plasma on GAMMA 10/PDX
by: M. Sakamoto, et al.
Published: (2017-08-01) -
Molecular basis of Kir6.2 mutations causing neonatal diabetes and neonatal diabetes with neurological features
by: Proks, P, et al.
Published: (2005)